杂志简称：appl microbiol biot
中文译名：《应用微生物学与生物技术》
收录属性：高质量科技期刊（t3）, scie（2024版）, 目次收录（维普）, 目次收录（知网）,英文期刊,
自引率：6.20%
投稿方向：工程技术、biotechnology & applied microbiology生物工程与应用微生物
SCI/E期刊基本信息
出版周期：半月刊 地区：德国
中科院分区：2区
是否TOP：TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN 0175-7598；E-ISSN 1432-0614
杂志语言：英语
出版国家：德国
杂志官网 联系方式
出版地址：ONE NEW YORK PLAZA,SUITE 4600 ,NEW YORK,United States,NY,10004
杂志邮箱：
投稿网址：https://www.editorialmanager.com/amab/default1.aspx
杂志官方网址：https://www.springer.com/journal/253
出版商网址：http://www.springeronline.com
杂志投稿要求
投稿须知【杂志社官方网站信息】
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
Submission guidelines
Instructions for Authors
Springer is a participant of CrossCheck, a multi-publisher plagiarism detection initiative to screen published and submitted content for originality. CrossCheck consists of two products: a database of scholarly publications (CrossCheck) and a web-based tool (iThenticate) to check an authored work against that database.
This journal uses the plagiarism tool to detect instances of overlapping and similar text in submitted manuscripts and your manuscript may be screened upon submission for plagiarism against previously published works.
Authorship Policy
Authorship should incorporate and should be restricted to those who have contributed substantially to the work in one or more of the following categories:
• Conceived of or designed study
• Performed research
• Analyzed data
• Contributed new methods or models
• Wrote the paper
Author Contribution Statement
Authors must provide a short description of the contributions made by each listed author (please use initials). This will be published in a separate section in front of the Acknowledgments.
For example: AM and DB conceived and designed research. AM and BB conducted experiments. GR contributed new reagents or analytical tools. AM and GR analyzed data. AM wrote the manuscript. All authors read and approved the manuscript.
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.
Title Page
Please make sure your title page contains the following information.
Title
The title should be concise and informative.
Author information
The name(s) of the author(s)
The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
A clear indication and an active e-mail address of the corresponding author
If available, the 16-digit ORCID of the author(s)
If address information is provided with the affiliation(s) it will also be published.
For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.
Abstract
Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.
For life science journals only (when applicable)
Trial registration number and date of registration for prospectively registered trials
Trial registration number and date of registration, followed by “retrospectively registered”, for retrospectively registered trials